Related Experiment Video
Updated: Apr 28, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
1.8K
Quetiapine in tardive dyskinesia
International Journal of Psychiatry in Clinical Practice
|June 20, 2014
Summary
Tardive dyskinesia (TD), a side-effect of antipsychotics, may be reversible with certain atypical medications. Three cases showed positive responses to quetiapine, suggesting further research into its efficacy for treating TD.
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Tardive dyskinesia (TD) is a serious, potentially irreversible adverse effect of antipsychotic medications.
- The medico-legal implications of human rights legislation highlight the urgency of treating TD.
- Clozapine, while used for TD, has limitations due to agranulocytosis risks.
Purpose of the Study:
- To investigate the potential of quetiapine in reversing tardive dyskinesia.
- To present case studies of TD patients responding positively to quetiapine.
Main Methods:
- Case study analysis of three patients with tardive dyskinesia.
- Observation of patient response to quetiapine treatment.
Main Results:
- All three patients with TD demonstrated significant improvement with quetiapine treatment.
- Quetiapine appears to be a promising option for managing TD.
Conclusions:
- Quetiapine may offer a viable treatment option for tardive dyskinesia.
- Further robust research is warranted to confirm the efficacy of quetiapine in TD treatment.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
1.2K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.2K
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:28Drug Therapy
445
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
445